Brokerages Set GSK plc (LON:GSK) PT at GBX 1,842.50

GSK plc (LON:GSK) has earned a consensus recommendation of “Moderate Buy” from the seven brokerages that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is GBX 1,842.50 ($23.36).

A number of research firms have issued reports on GSK. Shore Capital restated a “buy” rating on shares of GSK in a research report on Wednesday, August 28th. Berenberg Bank restated a “buy” rating and set a GBX 1,820 ($23.07) target price on shares of GSK in a research report on Tuesday, September 10th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 1,850 ($23.45) target price on shares of GSK in a research report on Tuesday, September 3rd.

Insider Activity

In related news, insider Elizabeth (Liz) McKee Anderson purchased 446 shares of the stock in a transaction dated Monday, September 23rd. The stock was bought at an average cost of GBX 2,051 ($26.00) per share, with a total value of £9,147.46 ($11,596.68). Also, insider Jonathan Symonds bought 7,150 shares of the stock in a transaction that occurred on Wednesday, October 30th. The shares were acquired at an average cost of GBX 1,394 ($17.67) per share, with a total value of £99,671 ($126,357.76). Insiders purchased a total of 7,604 shares of company stock valued at $10,893,038 in the last ninety days. 1.61% of the stock is owned by insiders.

GSK Price Performance

The stock’s 50-day moving average is GBX 1,449.02 and its 200-day moving average is GBX 1,558.36. The firm has a market cap of £54.84 billion, a P/E ratio of 1,184.07, a price-to-earnings-growth ratio of 1.24 and a beta of 0.31. The company has a current ratio of 0.82, a quick ratio of 0.73 and a debt-to-equity ratio of 123.04. GSK has a 52-week low of GBX 1,282.50 ($16.26) and a 52-week high of GBX 1,823.50 ($23.12).

GSK Announces Dividend

The business also recently declared a dividend, which will be paid on Thursday, January 9th. Stockholders of record on Thursday, November 14th will be paid a GBX 15 ($0.19) dividend. The ex-dividend date of this dividend is Thursday, November 14th. This represents a dividend yield of 1.03%. GSK’s dividend payout ratio (DPR) is presently 5,309.73%.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.